{"database": "lobbying", "table": "lobbying_activities", "rows": [[2118478, "67798131-bfda-4a27-9d7c-380f57c748a9", "Q1", "KING & SPALDING LLP", 21632, "U.S. CHAMBER OF COMMERCE INSTITUTE FOR LEGAL REFORM", 2018, "first_quarter", "TOR", "Provisions in the Food, Drug & Cosmetic Act related to advertising involving drugs", "Congressional Budget Office (CBO),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2018-04-19T16:45:16.477000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2118478"], "units": {}, "query_ms": 0.42801513336598873, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}